Remove Acquisition Remove Invest Remove Marketing Remove Pricing
article thumbnail

Need investment capital?

Berkonomics

Preparing for the game… If you have been following our recent insights, you’ll be up to speed knowing that professional investors negotiate tough terms, from provisions of control over asset acquisition, eventual sale of the company, future investments, forced co-sale when others attempt to sell their shares and more.

Invest 296
article thumbnail

What Does the Post Crash VC Market Look Like?

Both Sides of the Table

What You Can Learn From Public Markets It doesn’t really take a genius to realize that what happens in the public markets will filter back to the private markets because the ultimate exit of these companies is either an IPO or an acquisition (often by a public company whose valuation is fixed daily by the market).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

GoodRx Prices IPO

socalTECH

Santa Monica-based prescription and healthcare marketplace operator GoodRx has priced its IPO, saying late last night that it is offering up 34,615,384 shares of its Class A common stock at $33.00 The company priced well above its initial offering range, which was $24.00 per share, indicating high investor interst in the company.

Pricing 113
article thumbnail

Avidity Biosciences Prices IPO

socalTECH

San Diego-based Avidity Bio , a biopharmaceuticals company working on oligonucleotide-based therapies, priced its IPO last night, saying that it will offer up 14,400,000 shares of its common stock at $18.00 The company priced above its initial estimated offering range of $14.00 READ MORE>>.

Pricing 113
article thumbnail

GoodRx Sets IPO Pricing Range

socalTECH

Santa Monica-based GoodRx , a developer of a digital healthcare and prescriptions service, has set an IPO pricing range of between $24.00 billion through its IPO on the NASDAQ Global Select Market. and $28.00 The company is looking to raise as much as $1.1 GoodRx has filed to trade as GDRX. Seelaus & Co., LLC and Ramirez & Co.,

article thumbnail

Avidity Biosciences Sets IPO Pricing Range

socalTECH

La Jolla-based Avidity Biosciences , which is developing oligonucleotide-based therapies for rare and serious diseases, has set the pricing range for its IPO, saying it is looking to sell 10 million shares at between $14.00 The company said it has applied to list on the Nasdaq Global Market as RNA. and $16.00

Pricing 113
article thumbnail

Where is the best source of early stage investment?

Berkonomics

If you have been following our recent insights, you’ll be up to speed knowing that professional investors negotiate tough terms, from provisions of control over asset acquisition, eventual sale of the company, future investments, forced co-sale when others attempt to sell their shares and more.

Invest 243